Explore 3 Stock Ideas & Industry Insights Download Free Report

Koninklijke Philips NV ADR

Company price
30.35 USD -0.16 ( 0.52%)
Last update at 2026-11-06T21:00:00Z
VOLUME
1789449
Market Cap
21038.27M

Momentum Score

…

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. It has strategic partnership agreements with TriHealth, Prisma Health, and the University Health System of San Antonio to help the health system standardize patient monitoring, drive interoperability, and lay the foundation for enterprise-wide platform; and Oulu University Hospital to deliver advanced image-guided therapy solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
29.79
Low
30.50
High
52 Week Price Range
14.63
Low
23.49
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
30.51
Dividend Yield
4.40%
Revenue TTM
18529.00M
Revenue Per Share
21.00
Gross Profit TTM
7194.00M
Debt / Equity
0.62
ROE
-15.09%
Net Debt
7029.00M
ROCE
-0.51%
Diluted EPS TTM
-0.64

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -1731.00M 509.00M 1490.00M 1529.00M 1503.00M
Minority interest -3.00M -4.00M 31.00M 28.00M 29.00M
Net income -1618.00M 612.00M 1187.00M 1168.00M 1090.00M
Selling general administrative 671.00M 599.00M 668.00M 631.00M 631.00M
Selling and marketing expenses 4609.00M 4258.00M 4606.00M 4682.00M 4500.00M
Gross profit 7194.00M 7168.00M 8781.00M 8875.00M 8553.00M
Reconciled depreciation 1602.00M 1323.00M 1520.00M 1402.00M 1089.00M
Ebit -116.00M 553.00M 1542.00M 1644.00M 1767.00M
Ebitda 1486.00M 2020.00M 3214.00M 3164.00M 2856.00M
Depreciation and amortization 1602.00M 1467.00M 1672.00M 1520.00M 1089.00M
Non operating income net other - - - 0.00M 0.00M
Operating income -116.00M 553.00M 1542.00M 1644.00M 1719.00M
Other operating expenses 17998.00M 16603.00M 17993.00M 17837.00M 16403.00M
Interest expense 258.00M 188.00M 204.00M 233.00M 264.00M
Tax provision -113.00M -103.00M 284.00M 337.00M 193.00M
Interest income 58.00M 149.00M 160.00M 69.00M 154.00M
Net interest income -200.00M -39.00M -44.00M -164.00M -204.00M
Extraordinary items 13.00M 2711.00M -10.00M -19.00M -213.00M
Non recurring - - - 0.00M 0.00M
Other items - - - 0.00M 0.00M
Income tax expense -113.00M -103.00M 284.00M 337.00M 193.00M
Total revenue 17827.00M 17156.00M 19535.00M 19482.00M 18121.00M
Total operating expenses 7365.00M 6615.00M 7239.00M 7230.00M 6835.00M
Cost of revenue 10633.00M 9988.00M 10754.00M 10607.00M 9568.00M
Total other income expense net -1615.00M -44.00M -52.00M -115.00M -2.00M
Discontinued operations 13.00M 2711.00M -10.00M -19.00M -213.00M
Net income from continuing ops -1618.00M 612.00M 1205.00M 1192.00M 1310.00M
Net income applicable to common shares -1608.00M 3319.00M 1187.00M 1167.00M 1090.00M
Preferred stock and other adjustments - - - 0.00M 0.00M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 30688.00M 30961.00M 27713.00M 26983.00M 26019.00M
Intangible assets 3526.00M 3650.00M 2997.00M 3466.00M 3589.00M
Other current assets 490.00M 493.00M 424.00M 477.00M 469.00M
Total liab 17405.00M 16487.00M 15812.00M 14358.00M 13902.00M
Total stockholder equity 13249.00M 14438.00M 11870.00M 12597.00M 12088.00M
Deferred long term liab 393.00M 598.00M 621.00M 592.00M 620.00M
Other current liab 3339.00M 3581.00M 3149.00M 3178.00M 3368.00M
Common stock 178.00M 177.00M 182.00M 179.00M 185.00M
Capital stock 178.00M 177.00M 182.00M 179.00M 185.00M
Retained earnings 6832.00M 9344.00M 7827.00M 8296.00M 8266.00M
Other liab 2201.00M 2564.00M 2372.00M 2474.00M 2532.00M
Good will 10238.00M 10637.00M 8014.00M 8654.00M 8503.00M
Other assets 2551.00M 1.00M 2744.00M 2682.00M 2862.00M
Cash 1172.00M 2303.00M 3226.00M 1425.00M 1688.00M
Cash and equivalents 1172.00M 2303.00M 3226.00M 1425.00M 1688.00M
Total current liabilities 7934.00M 7450.00M 7736.00M 6945.00M 7943.00M
Current deferred revenue 1696.00M 1491.00M 1239.00M 1170.00M 878.00M
Net debt 7029.00M 4676.00M 3708.00M 4022.00M 3133.00M
Short term debt 931.00M 506.00M 1229.00M 508.00M 1394.00M
Short long term debt 931.00M 506.00M 1229.00M 110.00M 1306.00M
Short long term debt total 8201.00M 6979.00M 6934.00M 5447.00M 4821.00M
Other stockholder equity 4751.00M 13513.00M 12028.00M 11766.00M 26428.00M
Property plant equipment 2638.00M 2699.00M 2682.00M 2866.00M 1509.00M
Total current assets 10259.00M 10347.00M 11227.00M 9439.00M 9572.00M
Long term investments 1197.00M 1056.00M 670.00M 481.00M 558.00M
Net tangible assets -122.00M 151.00M 1480.00M 1069.00M 616.00M
Short term investments 11.00M 2.00M 0.00M 1.00M 436.00M
Net receivables 4337.00M 3967.00M 4306.00M 4712.00M 4182.00M
Long term debt 7270.00M 6473.00M 5705.00M 3768.00M 3003.00M
Inventory 4049.00M 3450.00M 2993.00M 2773.00M 2674.00M
Accounts payable 1968.00M 1872.00M 2119.00M 2089.00M 2303.00M
Total permanent equity - - - 0.00M 0.00M
Noncontrolling interest in consolidated entity - - - 0.00M 0.00M
Temporary equity redeemable noncontrolling interests - - - 0.00M 0.00M
Accumulated other comprehensive income 1488.00M 748.00M -340.00M 652.00M 11903.00M
Additional paid in capital - - - 0.00M 0.00M
Common stock total equity - - 182.00M 0.00M 0.00M
Preferred stock total equity - - - 0.00M 0.00M
Retained earnings total equity - - - 0.00M 0.00M
Treasury stock - -476.00M -199.00M -201.00M -399.00M
Accumulated amortization - - - 0.00M 0.00M
Non currrent assets other 381.00M 355.00M 303.00M 226.00M 211.00M
Deferred long term asset charges - - - 0.00M 0.00M
Non current assets total 20429.00M 20613.00M 16486.00M 17544.00M 16447.00M
Capital lease obligations 1082.00M 1220.00M 1215.00M 1381.00M 236.00M
Long term debt total 7018.00M 6473.00M 5705.00M 4877.00M 3239.00M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -1487.00M -3672.00M -1316.00M -603.00M -1486.00M
Change to liabilities 52.00M 219.00M 411.00M -369.00M 311.00M
Total cashflows from investing activities -1487.00M -3672.00M -1316.00M -603.00M -1486.00M
Net borrowings 1091.00M -251.00M 783.00M 109.00M 160.00M
Total cash from financing activities 500.00M -2347.00M 483.00M -1665.00M -1192.00M
Change to operating activities -282.00M 414.00M -47.00M 149.00M -320.00M
Net income -1618.00M 612.00M 1205.00M 1192.00M 1310.00M
Change in cash -1131.00M -923.00M 1801.00M -263.00M -251.00M
Begin period cash flow 2303.00M 3226.00M 1425.00M 1688.00M 1939.00M
End period cash flow 1172.00M 2303.00M 3226.00M 1425.00M 1688.00M
Total cash from operating activities -173.00M 1629.00M 2777.00M 2031.00M 1780.00M
Issuance of capital stock 12.00M 23.00M 46.00M 58.00M 94.00M
Depreciation 1602.00M 1323.00M 1520.00M 1402.00M 1089.00M
Other cashflows from investing activities -681.00M 49.00M -13.00M 385.00M -174.00M
Dividends paid 412.00M 482.00M 1.00M 453.00M 401.00M
Change to inventory -572.00M -581.00M -584.00M -175.00M -394.00M
Change to account receivables -342.00M -39.00M 87.00M -274.00M -97.00M
Sale purchase of stock -187.00M -1636.00M -343.00M -1376.00M -1042.00M
Other cashflows from financing activities 2559.00M 50.00M 1079.00M 867.00M 1318.00M
Change to netincome 1292.00M 432.00M 392.00M 319.00M 748.00M
Capital expenditures 806.00M 763.00M 942.00M 1013.00M 843.00M
Change receivables - - - 0.00M 0.00M
Cash flows other operating - - - 0.00M 0.00M
Exchange rate changes - - - 0.00M 0.00M
Cash and cash equivalents changes - - - 0.00M 0.00M
Change in working capital -1144.00M 13.00M -133.00M -669.00M -500.00M
Stock based compensation 95.00M 108.00M 115.00M 98.00M -485.00M
Other non cash items 1005.00M -324.00M -214.00M -329.00M 173.00M
Free cash flow -979.00M 866.00M 1835.00M 1018.00M 937.00M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
PHG
Koninklijke Philips NV ADR
-0.16
0.52%
30.35 - 14.29 1.14 1.58 1.58 -308.94
ABT
Abbott Laboratories
-0.03
0.03%
109.93 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC
-3.04
2.90%
101.80 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation
-9.21
2.75%
325.87 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG
-2.15
4.12%
49.85 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Koninklijke Philips NV ADR

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. It has strategic partnership agreements with TriHealth, Prisma Health, and the University Health System of San Antonio to help the health system standardize patient monitoring, drive interoperability, and lay the foundation for enterprise-wide platform; and Oulu University Hospital to deliver advanced image-guided therapy solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Philips Center, Amsterdam, Netherlands, 1096 BC

31 20 597 7777

70741

Name Title Year Born
Dr. Paulus A. Stoffels M.D., Ph.D. Independent Vice Chairman of Supervisory Board & Sec. 1962
Mr. Abhijit Bhattacharya Exec. VP, CFO & Member of the Board of Management 1961
Mr. Marnix J. van Ginneken Exec. VP, Chief Legal Officer & Member of the Board of Management 1973
Mr. François Adrianus van Houten Advisor 1960
Mr. Roy Jakobs CEO & Pres 1974
Mr. Willem Appelo Chief Operations Officer 1965
Mr. Leandro Mazzoni Head of Investor Relations NA
Ms. Daniela Seabrook Exec. VP & Chief HR Officer 1973
Mr. Sean Carney Chief Design Officer NA
Mr. Jeroen Tas Exec. Officer 1959

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…